From guideline to clinic: treatment adherence in dermatology

Abstract

According to consensus recommendations, real-world registries complement randomized trial evidence, a finding echoed by several independent groups. When protocols are compared, cost considerations continue to shape adoption in smaller units, although confirmatory data are still limited. Longitudinal data show that pre-analytical factors account for a large share of observed variance, and this trend is expected to continue. According to consensus recommendations, cost considerations continue to shape adoption in smaller units, pending validation in prospective studies.

Emerging evidence indicates that cost considerations continue to shape adoption in smaller units, which has direct implications for daily practice. When protocols are compared, patient selection criteria deserve closer scrutiny, as discussed in the accompanying commentary.

Open questions

Emerging evidence indicates that cross-disciplinary review changes the initial assessment in a sizeable minority of cases, which has direct implications for daily practice. When protocols are compared, digital tooling shortens time-to-decision considerably, with meaningful differences between subgroups.

Limitations

Longitudinal data show that early intervention correlates with better long-term outcomes, which has direct implications for daily practice. Emerging evidence indicates that cost considerations continue to shape adoption in smaller units, particularly in resource-constrained settings. From a workflow perspective, training and accreditation are decisive for reproducibility, and this trend is expected to continue. Contrary to earlier assumptions, variability between operators remains a key limitation, with meaningful differences between subgroups.

Background

According to consensus recommendations, real-world registries complement randomized trial evidence, pending validation in prospective studies. In routine practice, training and accreditation are decisive for reproducibility, as discussed in the accompanying commentary. In routine practice, pre-analytical factors account for a large share of observed variance, although confirmatory data are still limited.

From a workflow perspective, cost considerations continue to shape adoption in smaller units, as discussed in the accompanying commentary. When protocols are compared, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, with meaningful differences between subgroups. When protocols are compared, threshold harmonization is still an open question, with meaningful differences between subgroups. According to consensus recommendations, pre-analytical factors account for a large share of observed variance, which has direct implications for daily practice. Across multiple cohorts, threshold harmonization is still an open question, particularly in resource-constrained settings.